{"id":"W2968760378","doi":"10.1177/2475530319867095","title":"Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P","year":2019,"lang":"en","type":"article","venue":"Journal of Psoriasis and Psoriatic Arthritis","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Secukinumab; Plaque psoriasis; Psoriasis; Internal medicine; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001434259,0.0003557344,0.0008796728,0.0001644223,0.0002101105,0.0004707932,0.0003069387,0.0003460334,0.002639862],"category_scores_gemma":[0.0008051697,0.0001549753,0.001168542,0.000186669,0.0003837995,0.0003337198,0.0002045598,0.001304092,0.0002849216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002837083,"about_ca_system_score_gemma":0.0004944927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003261297,"about_ca_topic_score_gemma":0.0007252811,"domain_scores_codex":[0.9996266,0.0001915435,0.00003070836,0.00004985951,0.0000545185,0.0000466704],"domain_scores_gemma":[0.9995189,0.0001590878,0.000124036,0.00004353318,0.00003065127,0.0001239042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3700635,0.01580807,0.01452725,0.002368859,0.002911272,0.000349716,0.0001993239,0.0009959232,0.03153997,0.0003921772,0.004450127,0.5563939],"study_design_scores_gemma":[0.5078331,0.383288,0.08004035,0.0004883063,0.002541605,0.001917166,0.0001200852,0.001406536,0.008103173,0.0005035282,0.01371588,0.00004221337],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701487,0.02510843,0.0006223768,0.0007573086,0.0001789659,0.0005491068,0.0003615444,0.00004082326,0.002232768],"genre_scores_gemma":[0.9870461,0.009395439,0.001050714,0.0006119863,0.0003364121,0.0002616835,0.0005249748,0.00001268279,0.0007599459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002639862,"threshold_uncertainty_score":0.008831203,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008997813675163136,"score_gpt":0.2217314020076513,"score_spread":0.2127335883324881,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}